🦊/Investors

Amino CollectiveFull Portfolio

38 tracked investments · listed companies and verified rows first

Animaanima.supply𝕏Mar 2024 · $12M

Anima is a gaming and interactive technology company that uses artificial intelligence to create virtual characters and worlds.

AI & Machine LearningConsumerGaming

Co-investorsCoinbase VenturesNarcissus VenturesHummingbird VenturesMolten VenturesY Combinator

ExpressionEditsexpressionedits.comMay 2024 · $13M

ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.

AI & Machine LearningBiotechDeep Tech

Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)

Co-investorsBlueYard CapitalHAWKTAILOctopus VenturesAcequia Capital (AceCap)redalpineWilbe Capital

Fundrbirdfundrbird.com

Fundrbird provides software solutions for GP (general partner) firms to build and scale their fund management operations.

Enterprise SoftwareFintechSaaS

Co-investorsCuriosity VCEndeit CapitalHolland CapitalMundi VenturesPride Capital PartnersRevent+4 more

Junctionjunction.aiMar 2025 · $18M

Junction AI is a Managed Intelligence Partner that builds, deploys, and manages production AI systems micro-tuned on a company's proprietary data, with built-in compliance rules, audit trails, and human-in-the-loop review.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsHawke VenturesCreandumInflect HealthOmnivorePoint NineY Combinator

Kernal Biologicskernalbio.comin𝕏Series A · Jul 2022 · $25M

Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inBurak YILMAZ(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)

Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesHOF CapitalHummingbird VenturesSAV (Scale Asia Ventures)+2 more

Lirlirtx.comin

Lir develops AI-driven viral vector engineering for gene therapy, using machine learning to optimize AAV (adeno-associated virus) vectors for improved dose efficiency, tissue targeting, and immune evasion.

AI & Machine LearningBiotechDeep Tech

Killian Hanlon(Co-founder)inHugh O'Brien(Co-founder)in

Co-investorsFly Ventures

Nostosnostos-genomics.comin𝕏Pre-Seed · Feb 2022

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases.

AI & Machine LearningBiotechDigital HealthHealthtechBerlin, DE

David Gorgan(Founder)inRocio Acuna Hidalgo(CTO)in

Co-investors42CAPAcequia Capital (AceCap)Entrepreneur FirstFaberFrontline Ventures

Rematiqrematiq.comin

Rematiq builds an AI-driven platform for product and regulatory compliance in life sciences, connecting requirements, regulations, evidence and submissions in one system and automating traceability, compliance checks and document generation.

AI & Machine LearningHealthtechSaaS

David Boutellier-Saxer(Founder)in

Co-investorsProject A Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AI-Native Drug Discovery CROCalibreCancer Drug Discovery PlatformClinical Trial AI PlatformClinical Trials PlatformClinician CopilotDrug Discovery Prediction PlatformEnterprise AI Context GraphExscientiaGene Therapy PlatformGenomic Data PlatformHealth Data Integration PlatformLindusLiquid Biopsy PlatformMedicinal Plant Drug DiscoverymRNA Cancer TreatmentNanopore Proteomics PlatformPrecision Fermentation Drug DiscoveryProtein Design PlatformRNA Therapeutics ManufacturingScale MedicineScience IP-NFT MarketplaceScientific R&D AutomationSubstrate BioSynthetic DNA Gene ExpressionTelemedicine PlatformTextile Waste RecyclingTranscriptome Discovery PlatformVirtual Patient ModelingWomen's Health Digital Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.